Earnings Preview: Moderna to Report Financial Results Pre-market on May 01
Moderna Options Spot-On: On April 30th, 50,904 Contracts Were Traded, With 771K Open Interest
Unusual Options Activity: SMCI, EBAY and Others Attract Market Bets, SMCI V/OI Ratio Reaches 477.3
Preview: Moderna's Earnings
Asthma and HIV drugs drive performance growth. GlaxoSmithKline (GSK.US) Q1 profits exceeded expectations, maintaining the annual performance outlook.
The company's profits in the first quarter exceeded expectations, particularly strong sales of asthma and HIV treatment drugs offset the negative impact of the overall vaccine Business line sales performance being below expectations.
Unusual Options Activity: WFC, IP and Others Attract Market Bets, WFC V/OI Ratio Reaches 171.2
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
Express News | CytomX Therapeutics Presents Preclinical Data for Mrna Encoded Masked Il-12 Molecule in Collaboration With Moderna at AACR Annual Meeting
CytomX Therapeutics Presents Preclinical Data for MRNA Encoded Masked IL-12 Molecule in Collaboration With Moderna at AACR Annual Meeting
Bernstein Adjusts Moderna Price Target to $28 From $39, Maintains Market Perform Rating
Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot -- Barrons.com
HSBC Upgrades Moderna(MRNA.US) to Buy Rating, Cuts Target Price to $49
Will the US Stock Market's Rebound Ignite Your Next Trade?
Express News | Moderna : HSBC Cuts Target Price to $49 From $58
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Novavax Told by FDA to Conduct Additional Study for COVID Vaccine - Report
Moderna Options Spot-On: On April 25th, 99,736 Contracts Were Traded, With 783.64K Open Interest
Express News | Moderna Shares Lose Ground With Volume Spick in Late Afternoon, Last Down 2%; Pfizer Shares Lose Some Steam, Last up 0.6%
Moderna (NasdaqGS:MRNA) Sees 11% Share Price Surge Over Last Week